Effects of olmesartan medoxomil (OLM) and valsartan (VAL) on the renin-angiotensin-aldosterone system (RAAS) in healthy normal subjects

被引:0
|
作者
Jones, M
Sealey, J
Laragh, J
机构
[1] Sankyo Pharma Inc, Phase Res 4, Parsippany, NJ USA
[2] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
关键词
Olmesartan; plasma renin activity; valsartan;
D O I
10.1016/j.amjhyper.2005.03.178
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:65A / 65A
页数:1
相关论文
共 15 条
  • [1] Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: Relation to the renin-aldosterone system
    Resnick, LM
    Catanzaro, D
    Sealey, JE
    Laragh, JH
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (03) : 203 - 208
  • [2] Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system
    Resnick, L. M.
    Catanzaro, D.
    Sealey, J. E.
    Laragh, J. H.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (06): : 35 - 41
  • [3] Effect of the Renin-Angiotensin-Aldosterone System Reactivity on Endothelial Function and Modulative Role of Valsartan in Male Subjects with Essential Hypertension
    Jasiczek, Jakub
    Trocha, Malgorzata
    Derkacz, Arkadiusz
    Szahidewicz-Krupska, Ewa
    Doroszko, Adrian
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (24)
  • [4] Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19)
    Albashir, Ahmed Abdalazim Dafallah
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (01) : 51 - 56
  • [5] Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration
    Isshiki, Masashi
    Sakuma, Ichiro
    Hayashino, Yasuaki
    Sumita, Takashi
    Hara, Kazuo
    Takahashi, Kazuhisa
    Shiojima, Ichiro
    Satoh-Asahara, Noriko
    Kitazato, Hiroji
    Ito, Daisuke
    Saito, Daigo
    Hatano, Masako
    Ikegami, Yuichi
    Iida, Shinichiro
    Shimada, Akira
    Noda, Mitsuhiko
    ENDOCRINE JOURNAL, 2020, 67 (11) : 1127 - 1138
  • [6] Evaluation of the inhibitory effects of telmisartan on drug-induced renin-angiotensin-aldosterone system activation in normal dogs
    Konta, M.
    Nagakawa, M.
    Sakatani, A.
    Akabane, R.
    Miyagawa, Y.
    Takemura, N.
    JOURNAL OF VETERINARY CARDIOLOGY, 2018, 20 (05) : 376 - 383
  • [7] Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients
    Ichikawa, Shuichi
    Takayama, Yoshiaki
    RUSSIAN JOURNAL OF CARDIOLOGY, 2011, (03): : 33 - 39
  • [8] EFFECTS OF PHARMACOLOGICAL MODULATION OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ON SALT SENSITIVITY IN PATIENTS WITH BORDERLINE HYPERTENSION
    BORGHI, C
    BOSCHI, S
    COSTA, FV
    BACCHELLI, S
    ESPOSTI, DD
    PICCOLI, M
    AMBROSIONI, E
    JOURNAL OF HYPERTENSION, 1993, 11 : S248 - S249
  • [9] Effect of exercise training on the renin-angiotensin-aldosterone system in healthy individuals: a systematic review and meta-analysis
    Goessler, Karla
    Polito, Marcos
    Cornelissen, Veronique Ann
    HYPERTENSION RESEARCH, 2016, 39 (03) : 119 - 126
  • [10] Effects of Renin-Angiotensin-Aldosterone System Blockade on Chlorhexidine Gluconate-Induced Sclerosing Encapsulated Peritonitis in Rats
    Kocak, Gulay
    Azak, Alper
    Astarci, Hesna Muzeyyen
    Huddam, Bulent
    Karaca, Gokhan
    Ceri, Mevlut
    Can, Murat
    Sert, Mehmet
    Duranay, Murat
    THERAPEUTIC APHERESIS AND DIALYSIS, 2012, 16 (01) : 75 - 80